Certified by Founder Lodge
Delos Capital 康禧全球投資基金
China - Hong Kong
INVESTOR
1 Disclosed Funding Rounds $25,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
By finding innovation on the forefront of science and technology, then funding and fostering its growth and the journey across continents and cultures, Delos Capital Partners/Delos Life Scien
| Company | Date | Round | Raised |
|---|---|---|---|
ECCOGENE 诚益生物 |
June, 12 ,2023 | Series B | $25,000,000 |
Instylla |
August, 16 ,2023 | Unknown | $30,000,000 |
Avenzo Therapeutics |
September, 23 ,2025 | Series B | $60,000,000 |
ECCOGENE 诚益生物
Instylla
Avenzo Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)